← Browse by Condition
Medical Condition

muscle invasive ureter urothelial carcinoma

Total Trials
1
Recruiting Now
1
Trial Phases
Phase 2, Phase 3
NCT05987241 Phase 2, Phase 3
Recruiting

Testing the Role of DNA Released From Tumor Cells Into the Blood in Guiding the Use of Immunotherapy After Surgical Removal of the Bladder, Kidney, Ureter, and Urethra for Urothelial Cancer Treatment, MODERN Study

Enrollment
992 pts
Location
United States, Canad...
Sponsor
National Cancer Institute (NCI...
View Trial →